CLINICAL_TRIALS
trial_result
· 2021-05-07
Clinical Trial Update: Daratumumab for the Treatment of Patients With AL Amyloidosis [Phase 1, Phase 2]
Summary
Phase 1/2 trial evaluating daratumumab for AL amyloidosis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Medical Center | Conditions: AL Amyloidosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-05-07